Beihai Gofar Chuanshan Biological Co., Ltd. (SHA:600538)

China flag China · Delayed Price · Currency is CNY
6.85
-0.05 (-0.72%)
Apr 29, 2026, 3:00 PM CST
30.23%
Market Cap 3.59B
Revenue (ttm) 328.24M
Net Income (ttm) -87.62M
Shares Out 524.20M
EPS (ttm) -0.17
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 14,403,700
Average Volume 17,353,133
Open 6.83
Previous Close 6.90
Day's Range 6.75 - 6.96
52-Week Range 5.11 - 7.70
Beta 0.16
RSI 54.62
Earnings Date Apr 18, 2026

About SHA:600538

Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, engages in the distribution of pharmaceutical products in China. It operates through Pharmaceutical Distribution [Industry]; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails various medicines and medical devices through directly operated and franchised chain drugstores. It also provides pearl eye drops, pearl powder, and pearl layer powder under the Haibao brand; weichangning ... [Read more]

Sector Materials
Founded 1993
Employees 453
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600538
Full Company Profile

Financial Performance

In 2025, SHA:600538's revenue was 328.24 million, a decrease of -3.59% compared to the previous year's 340.47 million. Losses were -87.62 million, -6.64% less than in 2024.

Financial Statements

News

There is no news available yet.